20 stocks in focus today: Signature Global, IndusInd Bank, pharma, railway and power counters
From Signature Global’s ₹920-crore construction contracts to IndusInd Bank’s RBI approval for a stockbroking subsidiary, today’s watchlist features major updates across real estate, banking, pharma, railways and clean energy, with NBCC, RITES and Emcure Pharma also in focus.
Signature Global has awarded construction contracts to KEC International Ltd and NCC for a premium housing project in Gurugram. The project, 'Sarvam at DXP Estate', will comprise 11 residential towers with 1,798 units and a development area of 5 million sq. ft. IndusInd Bank received RBI approval to establish a wholly-owned subsidiary for stockbroking services.
Shares of IndusInd Bank rose 1.9% on the BSE. Novartis India terminated a partnership with Dr Reddy’s Laboratories, allowing Novartis to regain exclusivity over certain products. Emcure Pharma received a Voluntary Action Indicated (VAI) status from the USFDA for its Sanand, Ahmedabad facility. AstraZeneca Pharma India received approval to import Enhertu for an additional indication in treating HER2-positive breast cancer.
Gland Pharma signed a strategic agreement with a global pharmaceutical company for technology transfer, manufacturing, and supply of sterile injectable products. RITES Ltd signed a memorandum of understanding with HPCL to provide consultancy services for railway siding infrastructure. Neetu Yoshi Limited commenced production at its new Haridwar facility, doubling manufacturing capabilities.
Fujiyama Power Systems commissioned a 2 GW power-electronics manufacturing facility in Ratlam. NTPC Green Energy Ltd secured 200 MW/800 MWh of BESS capacity in West Bengal. Juniper Green Energy won a 230 MW solar energy tender. NBCC (India) Limited sold commercial space in Bharat Business Park, Delhi. Gamco Ltd increased its stake in Blissara Resorts Private Ltd to 33.33%.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
